Xtx Topco LTD Voyager Therapeutics, Inc. Transaction History

Xtx Topco LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$7.15 - $10.84 $3,474 - $5,268	-486 Reduced 1.98%	24,029 $223,000
Q4 2023 Feb 13, 2024	BUY	$6.28 - $8.81 $153,954 - $215,977	24,515 New	24,515 $206,000
Q3 2022 Nov 14, 2022	BUY	$5.57 - $7.47 $17,785 - $23,851	3,193 Added 12.51%	28,718 $170,000
Q2 2022 Aug 15, 2022	BUY	$4.82 - $10.09 $123,030 - $257,547	25,525 New	25,525 $151,000
Q3 2021 Nov 12, 2021	SELL	$2.63 - $4.12 $88,131 - $138,061	-33,510 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$3.94 - $5.44 $20,905 - $28,864	5,306 Added 18.81%	33,510 $138,000
Q1 2021 May 14, 2021	BUY	$4.61 - $9.04 $130,020 - $254,964	28,204 New	28,204 $133,000

130

34.7M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $223M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.